Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70053 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2025. Written by Yun-Yi Chen and 3 co-authors. Institution: Department of Urinary Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University CN, Suzhou, Jiangsu, China. Major MEDLINE topics: Ferroptosis, Docetaxel, Prostatic Neoplasms, Mitochondria. Cited 4 times so far (Crossref); 42 references.
Abstract (original language)
Docetaxel (DTX) is the preferred chemotherapeutic drug for prostate cancer (Pca), but the emergence of resistance has significantly reduced its efficacy. Polyphyllin VII (PPVII), a small molecule natural product derived from the traditional herb Paris polyphylla, has shown anticancer potential. This study aims to investigate the effects and mechanisms of PPVII combined with DTX in treating Pca. DTX‐sensitive DU‐145 cells and DTX‐resistant DU145/DTX cells were utilized for experiments in this study. Cell viability was assessed using MTT assays, while apoptosis, cell cycles, and ferroptosis were analyzed through flow cytometry and Western blot. Mitochondrial function was evaluated using immunofluorescence. Additionally, the expression of proteins related to the AMP‐activated protein kinase/mammalian target of the rapamycin/S6 kinase (AMPK/mTOR/S6K) signaling pathway was also examined to further investigate the underlying mechanisms. PPVII significantly enhanced the inhibitory effect of DTX, reduced cell viability ( p < 0.05), and promoted apoptosis ( p < 0.05) and cell cycle arrest ( p < 0.05). Specifically, PPVII increased the sensitivity of Pca cells to DTX by inducing ferroptosis and affecting mitochondrial function. Notably, the activation of the AMPK/mTOR/S6K signaling pathway played a crucial role in this process. This study revealed the synergistic effects and potential mechanisms of PPVII combined with DTX in Pca cells, and provided a reference for effectively overcoming DTX resistance in the clinical treatment of Pca.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urinary Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University CN, Suzhou, Jiangsu, China.
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Cite
APA
Chen, Y. Y., Hua, W. X., Huang, Y. H., & Ding, X. (2025). Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70053
Vancouver
Chen YY, Hua WX, Huang YH, Ding X. Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70053
BibTeX
@article{Chen2025,
author = {Chen, Yun-Yi and Hua, Wen-Xi and Huang, Yu-Hua and Ding, Xiang},
title = {Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70053}
}
EUVIMED